Matt Waldheim
Phasex (United States)(US)
Publications by Year
Research Areas
Virus-based gene therapy research, Metabolism and Genetic Disorders, Thyroid Disorders and Treatments, Aquaculture Nutrition and Growth, Cancer, Hypoxia, and Metabolism
Most-Cited Works
- → Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency(2018)138 cited
- → Messenger RNA (mRNA) delivery to the liver corrects ornithine transcarbamylase deficiency in a mouse disease model(2017)1 cited
- → 170. PhaseRx mRNA Technology Platform Uses SMARTT Polymer Technology ® to Target and Deliver mRNA to the Liver and Treat a Urea Cycle Disorder in a Mouse Disease Model(2016)